CNCE
Concert Pharmaceuticals Inc
Price:
8.37
USD
Volume:
10,724,200
United States | Biotechnology
CNCE Net Margin
As of 2025-05-24, the Net Margin of Concert Pharmaceuticals Inc (CNCE) is -245.7%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
CNCE Net Margin - Historical Value
| Date | Value |
|---|---|
| 2021-12-31 | -245.7% |
| 2020-12-31 | -946.8% |
| 2019-12-31 | -7109.1% |
| 2018-12-31 | -533.3% |
| 2017-12-31 | 66.4% |
| 2016-12-31 | -25350% |
| 2015-12-31 | 36.3% |
| 2014-12-31 | -368.6% |
| 2013-12-31 | -24% |
| 2012-12-31 | -159.4% |
CNCE Net Margin - Peers Comparison